{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:55:34Z","timestamp":1781754934135,"version":"3.54.5"},"reference-count":23,"publisher":"Norwegian Medical Association","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.20.0981","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T15:23:55Z","timestamp":1633101835000},"source":"Crossref","is-referenced-by-count":1,"title":["Monoklonal gammopati av klinisk betydning"],"prefix":"10.4045","volume":"141","author":[{"given":"Geir E.","family":"Tj\u00f8nnfjord","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik H.","family":"Schjesvold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Gulbrandsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Kristin","family":"Kvam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Rajkumar\u00a0SV, Dimopoulos\u00a0MA, Palumbo\u00a0A et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538\u201348. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25439696&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1470-2045(14)70442-5","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Wisl\u00f8ff\u00a0F, Andersen\u00a0P, Andersson\u00a0TR et al. Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway. I. Eur J Haematol 1991; 47: 333\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1761118&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1600-0609.1991.tb01856.x","DOI":"10.1111\/j.1600-0609.1991.tb01856.x"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Kyle\u00a0RA, Therneau\u00a0TM, Rajkumar\u00a0SV et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16571879&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa054494","DOI":"10.1056\/NEJMoa054494"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Landgren\u00a0O, Kyle\u00a0RA, Pfeiffer\u00a0RM et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009; 113: 5412\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19179464&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2008-12-194241","DOI":"10.1182\/blood-2008-12-194241"},{"key":"ref=5","unstructured":"Kreftregisterets \u00e5rsrapport for lymfoide maligniteter. Oslo: Kreftregisteret, 2018. https:\/\/www.kreftregisteret.no\/Generelt\/Rapporter\/Arsrapport-fra-kvalitetsregistrene\/Arsrapport-for-lymfom-og-KLL\/ Lest 1.3.2021."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Rajkumar\u00a0SV, Kyle\u00a0RA, Therneau\u00a0TM et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005; 106: 812\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15855274&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2005-03-1038","DOI":"10.1182\/blood-2005-03-1038"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Go\u00a0RS, Gundrum\u00a0JD, Neuner\u00a0JM. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis. Clin Lymphoma Myeloma Leuk 2015; 15: 177\u2013186.e4. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25445471&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.clml.2014.09.004","DOI":"10.1016\/j.clml.2014.09.004"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Merlini\u00a0G, Stone\u00a0MJ. Dangerous small B-cell clones. Blood 2006; 108: 2520\u201330. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16794250&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2006-03-001164","DOI":"10.1182\/blood-2006-03-001164"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Bida\u00a0JP, Kyle\u00a0RA, Therneau\u00a0TM et al. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 2009; 84: 685\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19648385&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4065%2F84.8.685","DOI":"10.4065\/84.8.685"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Sipe\u00a0JD, Benson\u00a0MD, Buxbaum\u00a0JN et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 2014; 21: 221\u20134. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25263598&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3109%2F13506129.2014.964858","DOI":"10.3109\/13506129.2014.964858"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Kyle\u00a0RA, Linos\u00a0A, Beard\u00a0CM et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992; 79: 1817\u201322. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1558973&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood.V79.7.1817.1817","DOI":"10.1182\/blood.V79.7.1817.bloodjournal7971817"},{"key":"ref=12","unstructured":"Hemminki\u00a0K, Li\u00a0X, F\u00f6rsti\u00a0A et al. Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health 2012; 12: 974. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23148499&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2F1471-2458-12-974"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Buxbaum\u00a0J, Gallo\u00a0G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am 1999; 13: 1235\u201348. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10626147&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0889-8588(05)70123-4","DOI":"10.1016\/S0889-8588(05)70123-4"},{"key":"ref=14","unstructured":"Berentsen\u00a0S, Ulvestad\u00a0E, Langholm\u00a0R et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 2006; 91: 460\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16585012&dopt=Abstract"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Randen\u00a0U, Tr\u00f8en\u00a0G, Tierens\u00a0A et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica 2014; 99: 497\u2013504. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24143001&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3324%2Fhaematol.2013.091702","DOI":"10.3324\/haematol.2013.091702"},{"key":"ref=16","unstructured":"Berentsen\u00a0S, Malecka\u00a0A, Randen\u00a0U et al. Cold agglutinin disease: where do we stand, and where are we going? Clin Adv Hematol Oncol 2020; 18: 35\u201344. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32511221&dopt=Abstract"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Ferri\u00a0C, Sebastiani\u00a0M, Giuggioli\u00a0D et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355\u201374. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15190522&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.semarthrit.2003.10.001","DOI":"10.1016\/j.semarthrit.2003.10.001"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Dalakas\u00a0MC. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. Ther Adv Neurol Disord 2018; 11: 1756285617746640. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29403542&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F1756285617746640","DOI":"10.1177\/1756285617746640"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Fermand\u00a0JP, Bridoux\u00a0F, Dispenzieri\u00a0A et al. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 2018; 132: 1478\u201385. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30012636&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2018-04-839480","DOI":"10.1182\/blood-2018-04-839480"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Li\u00a0J, Huang\u00a0Z, Duan\u00a0MH et al. Characterization of immunoglobulin \u03bb light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome. Ann Hematol 2012; 91: 1251\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22453306&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00277-012-1455-9","DOI":"10.1007\/s00277-012-1455-9"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Berentsen\u00a0S, Barcellini\u00a0W, D'Sa\u00a0S et al. Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood 2020; 136: 480\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32374875&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood.2020005674","DOI":"10.1182\/blood.2020005674"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Gertz\u00a0MA, Dispenzieri\u00a0A. Systemic amyloidosis recognition, prognosis, and therapy: A systematic review. JAMA 2020; 324: 79\u201389. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32633805&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Fjama.2020.5493","DOI":"10.1001\/jama.2020.5493"},{"key":"ref=23","unstructured":"Norsk selskap for hematologi. Handlingsprogram. https:\/\/www.legeforeningen.no\/foreningsledd\/fagmed\/Norsk-selskap-for-hematologi\/handlingsprogram\/ Lest 1.3.2021."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:19:19Z","timestamp":1781684359000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2021\/09\/klinisk-oversikt\/monoklonal-gammopati-av-klinisk-betydning"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":23,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,9,28]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.20.0981","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}